(19)
(11) EP 1 626 986 A2

(12)

(88) Date of publication A3:
20.01.2005

(43) Date of publication:
22.02.2006 Bulletin 2006/08

(21) Application number: 04732961.0

(22) Date of filing: 14.05.2004
(51) International Patent Classification (IPC): 
C07K 14/47(1995.01)
G01N 33/53(1985.01)
C07K 16/18(1995.01)
G01N 33/50(1980.01)
(86) International application number:
PCT/EP2004/005195
(87) International publication number:
WO 2004/101615 (25.11.2004 Gazette 2004/48)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 16.05.2003 US 471061 P

(71) Applicants:
  • Genova Ltd.
    Hamilton HM12 (BM)
  • Novartis Pharma GmbH
    1230 Wien (AT)

    AT 

(72) Inventors:
  • BOUGUELERET, Lydie
    1217 Meyrin (CH)
  • MAHE, Eve
    1217 Meyrin (CH)

(74) Representative: Leon, Susanna Iris et al
Novartis AG Corporate Intellectual Property P.O. Box
4002 Basel
4002 Basel (CH)

   


(54) SECRETED POLYPEPTIDE SPECIES ASSOCIATED WITH CARDIOVASCULAR DISORDERS